Literature DB >> 26018059

Landscape of Deceased Donors Labeled Increased Risk for Disease Transmission Under New Guidelines.

L M Kucirka1,2, M G Bowring1, A B Massie1, X Luo1, L H Nicholas1,3, D L Segev1,2.   

Abstract

Deceased donors are labeled increased risk for disease transmission (IRD) if they meet certain criteria. New PHS guidelines were recently implemented; the impact of these changes remains unknown. We aimed to quantify the impact of the new guidelines on the proportion of deceased donors labeled IRD, as well as demographic and clinical characteristics. We used Poisson regression with an interaction term for era (new vs. old guidelines) to quantify changes. Under the new guidelines, 19.5% donors were labeled IRD, compared to 10.4%, 12.2%, and 12.3% in the 3 most recent years under the old guidelines (IRR = 1.45, p < 0.001). Increases were consistent across OPOs: 44/59 had an increase in the percent of donors labeled IRD, and 14 OPOs labeled 25% of their donors IRD under the new guidelines (vs. 5 OPOs under the old). African-Americans were 52% more likely to be labeled IRD under the new guidelines (RR = 1.52, p = 0.01). There has been a substantial increase in donors labeled IRD under the new PHS guidelines; it is important to understand the mechanism and consequences to ensure an optimal balance of patient safety and organ utilization is achieved. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Donors and donation: donor-derived infections; guidelines; infection and infectious agents; viral: hepatitis C; viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)

Mesh:

Year:  2015        PMID: 26018059      PMCID: PMC4790457          DOI: 10.1111/ajt.13356

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  14 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

2.  Donor-derived infections in solid organ transplant recipients.

Authors:  P A Grossi; J A Fishman
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

Review 3.  Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-02       Impact factor: 8.086

4.  Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices.

Authors:  N Theodoropoulos; D P Ladner; M G Ison
Journal:  Transpl Infect Dis       Date:  2013-07-31       Impact factor: 2.228

5.  Determinants of the decision to accept a kidney from a donor at increased risk for blood-borne viral infection.

Authors:  Peter P Reese; Tara Tehrani; Mary Ann Lim; David A Asch; Emily A Blumberg; Maureen K Simon; Roy D Bloom; Scott D Halpern
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 8.237

6.  Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups.

Authors:  R Lorie Ros; Lauren M Kucirka; Priyanka Govindan; Harini Sarathy; Robert A Montgomery; Dorry L Segev
Journal:  Clin Transplant       Date:  2011-05-09       Impact factor: 2.863

Review 7.  Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

8.  Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation.

Authors:  Lauren M Kucirka; R Lorie Ros; Aruna K Subramanian; Robert A Montgomery; Dorry L Segev
Journal:  Arch Surg       Date:  2011-01

9.  Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1994-05-20

10.  Increases in heroin overdose deaths - 28 States, 2010 to 2012.

Authors:  Rose A Rudd; Len J Paulozzi; Michael J Bauer; Richard W Burleson; Rick E Carlson; Dan Dao; James W Davis; Jennifer Dudek; Beth Ann Eichler; Jessie C Fernandes; Anna Fondario; Barbara Gabella; Beth Hume; Theron Huntamer; Mbabazi Kariisa; Thomas W Largo; JoAnne Miles; Ashley Newmyer; Daniela Nitcheva; Beatriz E Perez; Scott K Proescholdbell; Jennifer C Sabel; Jessica Skiba; Svetla Slavova; Kathy Stone; John M Tharp; Tracy Wendling; Dagan Wright; Anne M Zehner
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-10-03       Impact factor: 17.586

View more
  12 in total

1.  Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.

Authors:  Mary G Bowring; Kyle R Jackson; Heather Wasik; Alicia Neu; Jacqueline Garonzik-Wang; Christine Durand; Niraj Desai; Allan B Massie; Dorry L Segev
Journal:  Transplantation       Date:  2019-12       Impact factor: 4.939

2.  Utilisation of kidneys from deceased donors at increased risk of infectious disease transmission: a step in the right direction.

Authors:  Chris J Callaghan; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

3.  Increased risk donor criteria: The time for change is now.

Authors:  Glenn K Wakam; Craig S Brown; Michael J Englesbe
Journal:  Clin Transplant       Date:  2020-05-06       Impact factor: 2.863

4.  Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation.

Authors:  Morgan L Cox; Michael S Mulvihill; Ashley Y Choi; Muath Bishawi; Asishana A Osho; John C Haney; Mani Daneshmand; Jacob A Klapper; Cameron R Wolfe; Matthew Hartwig
Journal:  J Heart Lung Transplant       Date:  2018-12-21       Impact factor: 10.247

5.  National Variation in Increased Infectious Risk Kidney Offer Acceptance.

Authors:  Courtenay M Holscher; Mary G Bowring; Christine E Haugen; Sheng Zhou; Allan B Massie; Sommer E Gentry; Dorry L Segev; Jacqueline M Garonzik Wang
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

6.  Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.

Authors:  Mary G Bowring; Ashton A Shaffer; Allan B Massie; Andrew Cameron; Niraj Desai; Mark Sulkowski; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Am J Transplant       Date:  2019-04-09       Impact factor: 8.086

Review 7.  Increased-risk donors and solid organ transplantation: current practices and opportunities for improvement.

Authors:  Craig S Brown; Glenn K Wakam; Michael J Englesbe
Journal:  Curr Opin Organ Transplant       Date:  2020-04       Impact factor: 2.269

8.  Effect of a Mobile Web App on Kidney Transplant Candidates' Knowledge About Increased Risk Donor Kidneys: A Randomized Controlled Trial.

Authors:  Elisa J Gordon; Min-Woong Sohn; Chih-Hung Chang; Gwen McNatt; Karina Vera; Nicole Beauvais; Emily Warren; Roslyn B Mannon; Michael G Ison
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

9.  Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Authors:  Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2017-12-05       Impact factor: 8.086

10.  Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ.

Authors:  Ethan Mark; David Goldsman; Pinar Keskinocak; Joel Sokol
Journal:  Transpl Infect Dis       Date:  2019-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.